Literature DB >> 15729519

Median nerve motor conduction velocity is concordant with myelin protein zero gene mutation.

Yi-Chung Lee1, Bing-Wen Soong, Yo-Tsen Liu, Kon-Ping Lin, Ker-Pei Kao, Zin-An Wu.   

Abstract

BACKGROUND: Myelin protein zero gene (MPZ) mutations may account for a small proportion of cases of Charcot-Marie-Tooth disease (CMT). Different MPZ mutations may be associated with different clinical and electrophysiological phenotypes.
OBJECTIVES: To expand our understanding of the characteristics of nerve conduction velocity (NCV) in patients with different MPZ mutations, the authors collected and analysed the NCV values from patients with MPZ mutations.
MATERIALS AND METHODS: The NCVs of fourteen patients from six families carrying MPZ mutations of Val58Asp, Ser63Phe, Thr65Ile,Arg98Cys, Arg98His, and Ser233fs were collected retrospectively. Five of them had received nerve conduction studies (NCS) twice. The mutations were verified by polymerase chain reaction (PCR) amplifications and nucleotide sequencing. Scatterplot analyses of median motor NCV (MNCV) versus specific MPZ mutation were performed.
RESULTS: The median MNCV varied widely, with a mean of 16.3 m/s (SD = 7.7 m/s) and a range of 5.1-32.9 m/s. Median MNCVs of patients with particular MPZ mutations were similar. Moreover, Median MNCV did not change significantly over time.
CONCLUSIONS: There was concordance between median MNCV and specific MPZ mutations. However, median MNCV is not an ideal measure with which to distinguish CMT1B patients with MPZ mutations from CMT1A patients with PMP22 mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15729519     DOI: 10.1007/s00415-005-0621-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity.

Authors:  P Young; K Grote; G Kuhlenbäumer; O Debus; H Kurlemann; H Halfter; H Funke; E B Ringelstein; F Stögbauer
Journal:  J Neurol       Date:  2001-05       Impact factor: 4.849

2.  Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin.

Authors:  L Shapiro; J P Doyle; P Hensley; D R Colman; W A Hendrickson
Journal:  Neuron       Date:  1996-09       Impact factor: 17.173

3.  Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene.

Authors:  M G Marrosu; S Vaccargiu; G Marrosu; A Vannelli; C Cianchetti; F Muntoni
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

4.  Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.

Authors:  I V Mersiyanova; S M Ismailov; A V Polyakov; E L Dadali; V P Fedotov; E Nelis; A Löfgren; V Timmerman; C van Broeckhoven; O V Evgrafov
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

5.  Myelinated fibers in Charcot-Marie-Tooth disease type 1B with Arg98His mutation of Po protein.

Authors:  A Ohnishi; T Yamamoto; S Yamamori; K Sudo; Y Fukushima; M Ikeda
Journal:  J Neurol Sci       Date:  1999-12-15       Impact factor: 3.181

6.  Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.

Authors:  T D Bird; G H Kraft; H P Lipe; K L Kenney; S M Sumi
Journal:  Ann Neurol       Date:  1997-04       Impact factor: 10.422

Review 7.  Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration.

Authors:  R H Quarles
Journal:  Cell Mol Life Sci       Date:  2002-11       Impact factor: 9.261

8.  High frequency of mutations in codon 98 of the peripheral myelin protein P0 gene in 20 French CMT1 patients.

Authors:  H Rouger; E LeGuern; R Gouider; S Tardieu; N Birouk; M Gugenheim; P Bouche; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

Review 9.  Phenotypic clustering in MPZ mutations.

Authors:  Michael E Shy; Agnes Jáni; Karen Krajewski; Marina Grandis; Richard A Lewis; Jun Li; Rosemary R Shy; Janne Balsamo; Jack Lilien; James Y Garbern; John Kamholz
Journal:  Brain       Date:  2004-01-07       Impact factor: 13.501

10.  Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A.

Authors:  L J Valentijn; F Baas; R A Wolterman; J E Hoogendijk; N H van den Bosch; I Zorn; A W Gabreëls-Festen; M de Visser; P A Bolhuis
Journal:  Nat Genet       Date:  1992-12       Impact factor: 38.330

View more
  4 in total

1.  Cellular characterization of MPZ mutations presenting with diverse clinical phenotypes.

Authors:  Yi-Chung Lee; Kon-Ping Lin; Ming-Hong Chang; Yi-Chu Liao; Ching-Piao Tsai; Kwong-Kum Liao; Bing-Wen Soong
Journal:  J Neurol       Date:  2010-05-12       Impact factor: 4.849

2.  Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity.

Authors:  Yingying Chen; Eric C Bielefeld; Jeffrey G Mellott; Weijie Wang; Amir M Mafi; Ebenezer N Yamoah; Jianxin Bao
Journal:  J Assoc Res Otolaryngol       Date:  2021-01-07

3.  Two Novel Myelin Protein Zero Mutations in a Group of Chinese Patients.

Authors:  Bin Chen; Zaiqiang Zhang; Na Chen; Wei Li; Hua Pan; Xingao Wang; Yuting Ren; Yuzhi Shi; Hongfei Tai; Songtao Niu
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

4.  Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.

Authors:  Oranee Sanmaneechai; Shawna Feely; Steven S Scherer; David N Herrmann; Joshua Burns; Francesco Muntoni; Jun Li; Carly E Siskind; John W Day; Matilde Laura; Charlotte J Sumner; Thomas E Lloyd; Sindhu Ramchandren; Rosemary R Shy; Tiffany Grider; Chelsea Bacon; Richard S Finkel; Sabrina W Yum; Isabella Moroni; Giuseppe Piscosquito; Davide Pareyson; Mary M Reilly; Michael E Shy
Journal:  Brain       Date:  2015-08-25       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.